Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study without detailed documentation
Justification for type of information:
2-ethylhexanol and pentane-2,4-dione are two main hydrolysis prodcuts of the target substance. Properties of the the two substance are used for read-across.

Data source

Reference
Reference Type:
publication
Title:
The acute toxicity and primary irritancy of 2,4-pentanedione
Author:
Ballantyne B, Dodd DE, Myers RC, Nachreiner JJ
Year:
1986
Bibliographic source:
Drug Chem. Toxicol. 9: 133-146

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
not specified
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
Pentane-2,4-dione
EC Number:
204-634-0
EC Name:
Pentane-2,4-dione
Cas Number:
123-54-6
Molecular formula:
C5H8O2
IUPAC Name:
Pentane-2,4-dione

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Doses:
1, 0.71, 0.50, 0.25 ml/kg bw
No. of animals per sex per dose:
5

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
ca. 760 mg/kg bw
95% CL:
>= 655 - <= 890
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
ca. 570 mg/kg bw
95% CL:
>= 485 - <= 675
Clinical signs:
sluggishness, tremors, kyphosis, lacrimation, unsteady gait, comatose appearance and prostration.

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
LD50 value tested on rat was 570 / 760 mg/kg bw in female/male. The substance was classified as category 4 according to GHS.
Executive summary:

As the target substance hydrolyses rapidly (half-life < 30 minutes) the intrinsic properties are related to hydrolysis products of the target substance. This information is used as a supporting evidence on the toxicity of the target substance in CSA.